← Back to Search

PointCheck Cohort for Neutropenia

N/A
Waitlist Available
Led By Mark Sloan, MD
Research Sponsored by Leuko Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to two-weeks
Awards & highlights

Study Summary

This trial will help assess a new technology, PointCheck, for monitoring chemotherapy-induced neutropenia. The study will include 90 patients with cancer, who will use the technology twice during a session, and in an at-home setting. The trial will evaluate the usability of PointCheck and its accuracy and precision.

Eligible Conditions
  • Neutropenia
  • Tumors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to three-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to three-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PointCheck's Usability
System Usability Scale (0-100 higher scores indicates better usability)
Secondary outcome measures
Number of participants with device-related adverse events as assessed by CTCAE v5.0
PointCheck's Accuracy
PointCheck's Precision
+1 more
Other outcome measures
Diagnostic performance for a second cutoff

Trial Design

1Treatment groups
Experimental Treatment
Group I: PointCheck CohortExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PointCheck
2021
N/A
~100

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,646 Previous Clinical Trials
40,930,927 Total Patients Enrolled
37 Trials studying Neutropenia
6,728 Patients Enrolled for Neutropenia
Leuko Labs, Inc.Lead Sponsor
3 Previous Clinical Trials
374 Total Patients Enrolled
2 Trials studying Neutropenia
304 Patients Enrolled for Neutropenia
Mark Sloan, MDPrincipal InvestigatorBoston Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
PC001- A Study to Evaluate the Usability of PointCheck
2021. "PC001- A Study to Evaluate the Usability of PointCheck". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04448301.
~24 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top